BioSpace News Archive

Xequel Bio, Inc., a clinical stage biopharmaceutical company developing dermatologic and ophthalmic therapeutics utilizing its patented new chemical entity aCT1, announced the appointments of Michael J. Brubaker, Ph.D., as Chief Scientific Officer and Tony C. Tipton as Chief Operating Officer.

Vela Diagnostics announced that it has developed a PCR test kit to detect the monkeypox virus, for research use only.

International medical imaging IT and cybersecurity company Sectra will install its enterprise imaging system at Cooper University Health Care.

Synaptogenix, Inc. (Nasdaq: SNPX) (“the Company”), today announced changes to its Scientific Advisory Board (SAB) in preparation for Phase 2 data from its Phase 2b clinical trial of Bryostatin-1 for patients suffering from advanced and moderately severe Alzheimer’s disease (AD).

Circle Pharma, a company focused on developing macrocycle therapeutics against targets previously considered to be undruggable, has appointed Paul Park, MBA, as its Chief Business Officer.

Co-Diagnostics, Inc. (Nasdaq: CODX) (“Co-Dx” or the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be disclosing the global expansion of its OEM agreement with Bio Molecular Systems (BMS) at the Company’s customer and distributor update today at AACC.

Forecast to 2030,’ thoroughly examines the Test Phantoms industry to provide essential data & information for the targeted readers.

Forecast to 2030,’ thoroughly examines the Obsessive Compulsive Disorder industry to provide essential data & information for the targeted readers.

The report consists of quantitative and qualitative research on the market performed by our market experts.

According to the most recent analysis by Emergen Research, the size of the worldwide mass spectrometry market reached USD 4.36 billion in 2021 and is anticipated to experience a revenue CAGR of 6.1% over the projected period.